POLARITYTE, INC. (PTE) News Headlines

▮ More

Date

Headline

9/8/2022 8:31:00 AM PolarityTE Announces Resignation Of Jeff Dyer From Board

8/11/2022 4:15:35 PM PolarityTE Inc. Q2 Loss Decreases, but misses estimates

8/11/2022 4:09:47 PM PolarityTE Q2 Loss/share $0.49 Vs. Loss $1.01 Year Ago

8/11/2022 3:00:18 PM PolarityTE Q2 22 Earnings Conference Call At 4:30 PM ET

6/6/2022 8:17:40 AM PolarityTE Announces $8 Mln Registered Direct And Private Placement Offerings Priced At-The-Market Under Nasdaq Rules

5/16/2022 7:37:15 AM Amended: PolarityTE Inc. Q1 Loss Narrows, But Misses Estimates

5/16/2022 7:35:07 AM PolarityTE Q1 Adj Loss/shr $0.10 Vs Loss/shr $0.11 Prior Year

5/16/2022 7:30:10 AM PolarityTE Q1 22 Earnings Conference Call At 8:30 AM ET

5/13/2022 8:16:22 AM PolarityTE: FDA Grants RMAT Designation For SkinTE

5/13/2022 8:02:59 AM PolarityTE Says FDA Granted Regenerative Medicine Advanced Therapy Designation To SkinTE

3/30/2022 7:36:40 AM PolarityTE FY Loss Per Share $0.38 Vs Loss $1.16 Last Year

3/30/2022 7:30:09 AM PolarityTE Q4 21 Earnings Conference Call At 8:30 AM ET

1/18/2022 8:56:34 AM PolarityTE Gets FDA Nod To Commence Phase 3 Study Of SkinTE In Chronic Cutaneous Ulcer Indication

1/18/2022 8:02:32 AM PolarityTE : FDA Approves IND For Pivotal Phase 3 Study Of SkinTE To Support Chronic Cutaneous Ulcer Indication

1/3/2022 7:21:21 AM Pre-market Movers: CELZ, AFI, BLCT, AGE, PTE…

12/20/2021 8:38:36 AM PolarityTE Says Complete Response Filed To FDA's Clinical Hold Correspondence For SkinTE IND Appn

12/20/2021 8:05:16 AM PolarityTE Submits Complete Response To FDA's Clinical Hold Correspondence For SkinTE IND

11/10/2021 7:33:20 AM PolarityTE Q3 21 Earnings Conference Call At 8:30 AM ET

11/10/2021 7:04:21 AM PolarityTE Inc. Q3 adjusted earnings Beat Estimates

11/10/2021 7:02:31 AM PolarityTE Q3 Loss/shr Narrows To $0.01 From $0.18 Last Year

Polarityte, Inc. (PTE)